TTK Healthcare Limited (NSE:TTKHLTCARE)
929.40
+46.05 (5.21%)
Jun 19, 2026, 3:29 PM IST
TTK Healthcare Revenue
In the fiscal year ending March 31, 2026, TTK Healthcare had annual revenue of 8.57B INR with 6.96% growth. TTK Healthcare had revenue of 2.18B in the quarter ending March 31, 2026, with 14.51% growth.
Revenue
8.57B
Revenue Growth
+6.96%
P/S Ratio
1.53
Revenue / Employee
6.40M
Employees
1,339
Market Cap
13.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 8.57B | 557.88M | 6.96% |
| Mar 31, 2025 | 8.01B | 487.00M | 6.47% |
| Mar 31, 2024 | 7.53B | 276.84M | 3.82% |
| Mar 31, 2023 | 7.25B | 1.26B | 21.01% |
| Mar 31, 2022 | 5.99B | 1.23B | 25.88% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 584.62B |
| Cipla | 278.28B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 105.60B |
| Windlas Biotech | 9.04B |
| Ind-Swift Laboratories | 6.41B |
| GPT Healthcare | 4.73B |
| Tarsons Products | 4.23B |